A Phase I Study of the Wee 1 Kinase (Wee 1) Inhibitor AZD1775 (MK-1775) in Combination With Cisplatin and Radiation in Cervical Cancer (10041848, 10008224, 10008328)
Latest Information Update: 13 Jul 2017
At a glance
- Drugs Adavosertib (Primary) ; Cisplatin
- Indications Cervical cancer
- Focus Adverse reactions
- 30 Apr 2017 Planned primary completion date changed from 1 Mar 2017 to 1 Jun 2021.
- 30 Apr 2017 Planned primary completion date changed from 1 Mar 2017 to 1 Jun 2021.
- 08 Dec 2016 Planned primary completion date changed from 1 Aug 2016 to 1 Mar 2017.